Edition:
India

AnGes submits application for marketing approval for HGF gene therapy


Monday, 22 Jan 2018 

Jan 22 (Reuters) - AnGes Inc <4563.T> ::Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI). 

Company Quote

725.0
40.0 +5.84%
16 Aug 2019